These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27025633)

  • 21. Community-associated meticillin-resistant Staphylococcus aureus.
    DeLeo FR; Otto M; Kreiswirth BN; Chambers HF
    Lancet; 2010 May; 375(9725):1557-68. PubMed ID: 20206987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro miconazole susceptibility of meticillin-resistant Staphylococcus pseudintermedius and Staphylococcus aureus.
    Weese JS; Walker M; Lowe T
    Vet Dermatol; 2012 Oct; 23(5):400-e74. PubMed ID: 22830415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.
    Kuok CF; Hoi SO; Hoi CF; Chan CH; Fong IH; Ngok CK; Meng LR; Fong P
    Exp Biol Med (Maywood); 2017 Apr; 242(7):731-743. PubMed ID: 28118725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations.
    Paladino JA; Jacobs DM; Shields RK; Taylor J; Bader J; Adelman MH; Wilton GJ; Crane JK; Schentag JJ
    Int J Antimicrob Agents; 2014 Dec; 44(6):557-63. PubMed ID: 25282169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and molecular characteristics of nosocomial meticillin-resistant Staphylococcus aureus skin and soft tissue isolates from three Indian hospitals.
    Gadepalli R; Dhawan B; Kapil A; Sreenivas V; Jais M; Gaind R; Chaudhry R; Samantaray JC; Udo EE
    J Hosp Infect; 2009 Nov; 73(3):253-63. PubMed ID: 19782432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
    Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y
    Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
    Zuo GY; Zhang XJ; Han J; Li YQ; Wang GC
    BMC Complement Altern Med; 2015 Dec; 15():425. PubMed ID: 26627468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
    Lederer SR; Riedelsdorf G; Schiffl H
    Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
    Desbois AP; Gemmell CG; Coote PJ
    Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus.
    Huang V; Cheung CM; Kaatz GW; Rybak MJ
    Int J Antimicrob Agents; 2010 Jan; 35(1):25-9. PubMed ID: 19900792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus.
    Goldstein EJC; Citron DM; Warren YA; Tyrrell KL; Rybak MJ
    J Med Microbiol; 2008 Apr; 57(Pt 4):452-456. PubMed ID: 18349364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus.
    Yang W; Liu J; Blažeković B; Sun Y; Ma S; Ren C; Vladimir-Knežević S; Li C; Xing Y; Tian G; Wang Y
    BMC Complement Altern Med; 2018 May; 18(1):169. PubMed ID: 29848316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus.
    Oliveira DC; Tomasz A; de Lencastre H
    Lancet Infect Dis; 2002 Mar; 2(3):180-9. PubMed ID: 11944188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management and epidemiologic analyses of an outbreak due to methicillin-resistant Staphylococcus aureus.
    Goetz MB; Mulligan ME; Kwok R; O'Brien H; Caballes C; Garcia JP
    Am J Med; 1992 Jun; 92(6):607-14. PubMed ID: 1605142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug-resistant clones of community-associated meticillin-resistant Staphylococcus aureus isolated from Chinese children and the resistance genes to clindamycin and mupirocin.
    Wang L; Liu Y; Yang Y; Huang G; Wang C; Deng L; Zheng Y; Fu Z; Li C; Shang Y; Zhao C; Sun M; Li X; Yu S; Yao K; Shen X
    J Med Microbiol; 2012 Sep; 61(Pt 9):1240-1247. PubMed ID: 22595913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens.
    Younis W; AbdelKhalek A; Mayhoub AS; Seleem MN
    Curr Pharm Des; 2017; 23(14):2147-2157. PubMed ID: 28190396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repurposing niclosamide as a versatile antimicrobial surface coating against device-associated, hospital-acquired bacterial infections.
    Gwisai T; Hollingsworth NR; Cowles S; Tharmalingam N; Mylonakis E; Fuchs BB; Shukla A
    Biomed Mater; 2017 Jul; 12(4):045010. PubMed ID: 28471351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections.
    Thangamani S; Younis W; Seleem MN
    Sci Rep; 2015 Jun; 5():11596. PubMed ID: 26111644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent.
    Thangamani S; Mohammad H; Abushahba MF; Hamed MI; Sobreira TJ; Hedrick VE; Paul LN; Seleem MN
    Sci Rep; 2015 Nov; 5():16407. PubMed ID: 26553420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital.
    Nulens E; Broex E; Ament A; Deurenberg RH; Smeets E; Scheres J; van Tiel FH; Gordts B; Stobberingh EE
    J Hosp Infect; 2008 Apr; 68(4):301-7. PubMed ID: 18353496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.